Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Promising MIF inhibitor for prophylaxis and treatment of type 1 diabetes

April 1, 2004

Resorcinol derivatives for the treatment of diabetes claimed by Sankyo

April 1, 2004

Inhibitors of sodium-dependent glucose co-transporter emerge from Taisho research

April 1, 2004

Enrollment completed in phase II obesity study of AC-137

April 1, 2004

Amylin PYY obesity drug candidate enters phase I safety study

April 1, 2004

Exenatide LAR enters phase II study in patients with type 2 diabetes

April 1, 2004

Quigley completes pre-IND meeting for QR-333

April 1, 2004

Ajinomoto reports novel series of antidiabetic compounds

March 31, 2004

DeveloGen cites use of TGF BETA IG-H3 protein in treatment of obesity, diabetes, metabolic syndrome

March 31, 2004

Use of reboxetine for hot flashes claimed by patent

March 31, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...